| Charter Communications INC CHARTER COMMUNICATIONS ORD SHS CLASS A | 632.83 |
| Date/Time | 09/23 / 15:49 |
| Chg. / Chg.(%) | - / |
| Bid | - |
| Ask | - |
| Open | 632.83 |
| Previous Close | 625.25 |
| High | 632.83 |
| Low | 632.83 |
| Volume [USD] | 632.83 |
| Volume [Units] | 2 |
| Price fixings | 1 |
| ISIN | US16119P1084 |
| Security | 0HW4 |
| Exchange | London International |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| TradeGate | 527.50 |  |
1 |
| München | 523.80 | |
1 |
| Hamburg | 523.10 | |
0 |
| Frankfurt | 522.8000 | |
0 |
| Berlin | 523.40 | |
0 |
| Düsseldorf | 521.80 | |
0 |
| Hannover | 523.10 | |
0 |
| Vienna Globa.. | 525.40 | |
0 |
| Stuttgart | 523.900 | |
|
| Lang & Schwa.. | 522.60 |  |
|
| gettex | 525.700 | |
|
| NASDAQ | 611.4500 | |
931,374 |
| Cboe US | 611.56 | |
45,842 |
| IEX | 611.58 | |
40,910 |
| Mexico | 13,510.00 | |
210 |
| Xetra | 529.00 | 0 | |
| London Inter.. | 632.83 | 2 |
News
- Correction: Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis
08:13 - GlobeNewswire - Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis
08:00 - GlobeNewswire - Nyxoah announces the end of the Stabilisation Period and the Full Exercise of the Over-allotment Option
07:00 - GlobeNewswire - Uniserve reports results for fiscal year ended May 31, 2020
04:06 - GlobeNewswire - INFINITI QX60 Monograph previews design of next-generation three-row SUV
02:00 - GlobeNewswire
Real-time